Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignancies.
Ollila TA, Masel RH, Reagan JL, Lu S, Rogers RD, Paiva KJ, Taher R, Burguera-Couce E, Zayac AS, Yakirevich I, Niroula R, Barth P, Olszewski AJ.
Ollila TA, et al. Among authors: barth p.
Cancer. 2022 Sep 15;128(18):3319-3329. doi: 10.1002/cncr.34354. Epub 2022 Jul 11.
Cancer. 2022.
PMID: 35811461
Free PMC article.